HN

Hasmukhbhai Naranbhai Patel

Active Director Director DIN 01779722
DIN 01779722 First appointment Nov 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Nov 2006
Shareholding value •••• Premium profile

About Hasmukhbhai Naranbhai Patel

Data last updated:

Hasmukhbhai Naranbhai Patel is a Director at Ruja Impex Private Limited (since 2022) and Director at Kanku Infrastructure Private Limited (since 2018). The companies operate in Pharma, Real Estate and Construction and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹9.87 Cr; the largest is Ruja Impex Private Limited at ₹9.63 Cr (FY 2022). Earlier, Hasmukhbhai Naranbhai Patel was a Director at Apister Lifesciences Private Limited (2019–2025) and Director at Vim Meditech Private Limited (2024–2025) and 2 more.

DIN 01779722
Primary Designation Director
Industry Pharma
First Appointment 15 Nov 2006
Oldest Company Age 31 yrs
Largest company Ruja Impex Private Limited · ₹9.63 Cr (FY 2022)
Combined revenue ₹9.87 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ruja Impex Private Limited U51909GJ2012PTC073181
Director28 Mar 20222012₹9.63 Cr (FY 2022)Active
Kanku Infrastructure Private Limited U45200GJ2011PTC065643
Director28 Aug 20182011₹24.4 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apister Lifesciences Private Limited U24304GJ2017PTC097161
Director21 Jan 20192017₹73.56 Cr (FY 2025)Active
Vim Meditech Private Limited U33100GJ1994PTC021547
Director09 Mar 20241994₹53.98 Cr (FY 2024)Active
Star Sulphur Pvt Ltd U20299GJ1990PTC014392
Director15 Nov 20061990₹30.2 Lakh (FY 2024)Active
Director23 Apr 20151995Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Hasmukhbhai Naranbhai Patel

Directorship timeline

Open interactive timeline →
Kanku Infrastructure Private Limited
Goodluck Finstock And Leasing Limited
Ruja Impex Private Limited
Apister Lifesciences Private Limited
Premium access

Shareholding and investment profile for Hasmukhbhai Naranbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hasmukhbhai Naranbhai Patel

Hasmukhbhai Naranbhai Patel currently holds 2 directorships: Ruja Impex Private Limited (Director, since 28 Mar 2022, revenue ₹9.63 Cr (FY 2022)); Kanku Infrastructure Private Limited (Director, since 28 Aug 2018, revenue ₹24.4 Lakh (FY 2025)).

Hasmukhbhai Naranbhai Patel was first appointed on 15 Nov 2006 as Director at Star Sulphur Pvt Ltd. The most recent appointment on record is 09 Mar 2024 at Vim Meditech Private Limited.

The 2 current companies of Hasmukhbhai Naranbhai Patel that report revenue have a combined latest revenue of ₹9.87 Cr: Ruja Impex Private Limited ₹9.63 Cr (FY 2022); Kanku Infrastructure Private Limited ₹24.4 Lakh (FY 2025).

Hasmukhbhai Naranbhai Patel held 4 earlier board appointments: Apister Lifesciences Private Limited (Director, 21 Jan 2019 to 01 May 2025); Vim Meditech Private Limited (Director, 09 Mar 2024 to 04 Feb 2025); Star Sulphur Pvt Ltd (Director, 15 Nov 2006 to 24 Nov 2020); Goodluck Finstock And Leasing Limited (Director, from 23 Apr 2015).

The current boards of Hasmukhbhai Naranbhai Patel's companies include Dasharathbhai Ambalal Patel (Ruja Impex Private Limited), Babulal Amrutlal Patel (Kanku Infrastructure Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available